Back to Search
Start Over
Acadia downgraded to Equal Weight from Overweight at Morgan Stanley
- Source :
- The Fly. August 7, 2024
- Publication Year :
- 2024
-
Abstract
- Morgan Stanley analyst Jeffrey Hung downgraded Acadia Pharmaceuticals to Equal Weight from Overweight with a price target of $20, down from $28, post the Q2 report. While Nuplazid sales were [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.804140610